U.S. Markets close in 5 hrs 8 mins

U.S. Stock ETFs Try to Find Direction After Doubts Over Trade

This article was originally published on ETFTrends.com.

U.S. markets and stock ETFs swayed between gains and losses Wednesday as a new round of uncertainty over trade talks between the United States and China weighed on sentiment.

On Wednesday, the SPDR Dow Jones Industrial Average ETF (DIA) rose 0.3% while the  SPDR S&P 500 ETF (SPY) was 0.1% higher.

Weighing on investor confidence, trade talks hit a bump over Chinese purchases of U.S. agricultural goods, the Wall Street Journal reports.

“After a nice run, we are getting a little bit of pullback,” Mona Mahajan, U.S. investment strategist with Allianz Global Investors, told Reuters. “Part of that run was driven by U.S.-China trade perhaps thawing or starting to see some at least resolution or trade truce, so this headline that just broke is not great for that part of the story.”

The sudden development put a pause to the equity rally after optimism over a “phase one” trade deal between the U.S. and China helped lift stocks to record highs in recent sessions. Nevertheless, market participants remain sensitive to concerns that the high-level negotiations could be derailed.

Observers are also closely looking to see whether Washington will agree to remove previously enacted tariffs on Chinese imports to secure an initial trade deal with Beijing, rather than just softening threats of further levies expected on December 15.

“The euphoria of an imminent trade deal has dissipated,” Mike Loewengart, vice president of investment strategy at E*Trade, told the WSJ. “Expectations should be tempered given the back-and-forth we’ve seen over the past year.”

Additionally, the markets helped pare losses after Federal Reserve Chairman Jerome Powell signaled that the U.S. central bank was still willing to support economic growth if need be. While the Fed chief said monetary policy may not be adjusted after three interest-rate cuts this year, he added that they were open to reevaluating their position if conditions worsened. Powell's remarks showed a “slightly more dovish tone” than at his most recent press appearances.

“In other words, the pause is not set in stone,” Quincy Krosby, chief market strategist at Prudential Financial, told the WSJ.

For more information on the markets, visit our current affairs category.

POPULAR ARTICLES AND RESOURCES FROM ETFTRENDS.COM

READ MORE AT ETFTRENDS.COM >

  • Business
    Barrons.com

    Marijuana Stock Canopy Growth’s New CEO Isn’t a Reason to Buy Now

    (WEED) stock soared on Monday after the company said Constellation Brands Chief Financial Officer David Klein would be the pot seller's next CEO. Klein has a long road ahead to regain the trust of investors in Canopy stock (ticker: CGC). Shares have floundered since co-founder Bruce Linton was fired in July following disappointing results.

  • Should You Avoid A. O. Smith Corporation (AOS)?
    Business
    Insider Monkey

    Should You Avoid A. O. Smith Corporation (AOS)?

    It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? Truth be told, most hedge fund managers and other smaller players within this industry are very smart and skilled investors. Conversely, hedge funds' top 20 large-cap stock picks generated a return of 37.4% during the same 11-month period, with the majority of these stock picks outperforming the broader market benchmark.

  • How Does CarGurus, Inc. (NASDAQ:CARG) Affect Your Portfolio Volatility?
    Business
    Simply Wall St.

    How Does CarGurus, Inc. (NASDAQ:CARG) Affect Your Portfolio Volatility?

    If you own shares in CarGurus, Inc. (NASDAQ:CARG) then it's worth thinking about how it contributes to the volatility of your portfolio, overall. In finance, Beta is a measure of volatility. Modern finance theory considers volatility to be a measure of risk, and there are two main types of price volatility.

  • Should We Be Cautious About Kinder Morgan, Inc.'s (NYSE:KMI) ROE Of 6.0%?
    Business
    Simply Wall St.

    Should We Be Cautious About Kinder Morgan, Inc.'s (NYSE:KMI) ROE Of 6.0%?

    Does Kinder Morgan Have A Good ROE? Arguably the easiest way to assess company's ROE is to compare it with the average in its industry. However, this method is only useful as a rough check, because companies do differ quite a bit within the same industry classification.

  • Danish e-sports team holds world's first e-sports IPO
    Business
    Yahoo Finance Video

    Danish e-sports team holds world's first e-sports IPO

    Denmark-based Astralis Group is going public, with its IPO price set at $1.33, giving it a valuation of $75.5 million. Yahoo Finance's Dan Roberts, Brian Cheung and Julia La Roche discuss on YFi AM.

  • We're Hopeful That DigitalX (ASX:DCC) Will Use Its Cash Wisely
    Business
    Simply Wall St.

    We're Hopeful That DigitalX (ASX:DCC) Will Use Its Cash Wisely

    Having said that, unprofitable companies are risky because they could potentially burn through all their cash and become distressed. So, the natural question for DigitalX (ASX:DCC) shareholders is whether they should be concerned by its rate of cash burn. For the purpose of this article, we'll define cash burn as the amount of cash the company is spending each year to fund its growth (also called its negative free cash flow).

  • Has MRC Global Inc. (NYSE:MRC) Been Employing Capital Shrewdly?
    Business
    Simply Wall St.

    Has MRC Global Inc. (NYSE:MRC) Been Employing Capital Shrewdly?

    Today we are going to look at MRC Global Inc. (NYSE:MRC) to see whether it might be an attractive investment prospect. Specifically, we'll consider its Return On Capital Employed (ROCE), since that will give us an insight into how efficiently the business can generate profits from the capital it requires. First up, we'll look at what ROCE is and how we calculate it.

  • Should We Worry About Loblaw Companies Limited's (TSE:L) P/E Ratio?
    Business
    Simply Wall St.

    Should We Worry About Loblaw Companies Limited's (TSE:L) P/E Ratio?

    Today, we'll introduce the concept of the P/E ratio for those who are learning about investing. To keep it practical, we'll show how Loblaw Companies Limited's (TSE:L) P/E ratio could help you assess the value on offer. Loblaw Companies has a price to earnings ratio of 25.48, based on the last twelve months.

  • Do Hedge Funds Love Aimmune Therapeutics Inc (AIMT) ?
    Business
    Insider Monkey

    Do Hedge Funds Love Aimmune Therapeutics Inc (AIMT) ?

    That's why we believe it isn't a waste of time to check out hedge fund sentiment before you invest in a stock like Aimmune Therapeutics Inc (NASDAQ:AIMT). Aimmune Therapeutics Inc (NASDAQ:AIMT) was in 20 hedge funds' portfolios at the end of September. AIMT has experienced an increase in activity from the world's largest hedge funds lately.

  • Who Can Bring Back the Ted Baker Magic?
    Business
    Bloomberg

    Who Can Bring Back the Ted Baker Magic?

    Now it says pre-tax profit will be between 5 million pounds ($6.6 million) and 10 million pounds, far below previous expectations of between 25 million pounds and 30 million pounds. It also suspended the dividend. What was for many years one of Britain's best performing clothing retailers has been plunged into crisis after its founder Ray Kelvin — who dreamed up Ted Baker and his quirky, classy fashion sensibility — resigned in March after allegations of inappropriate behavior toward female employees such as unwanted hugs.

  • Business
    Market Exclusive

    Market Morning: Virgin Rocket, Blain Bashes Tesla, Softbank Bails on Wag, Banks Fret on Repo

    Virgin Galactic (NYSE:SPCE) shares are rocketing back into space, or at least to a $9.66 handle at time of writing, on the back of a Morgan Stanley (NYSE:MS) report predicting that shares could climb to $60 if the company executes its business goals. “…a chance to disrupt the multi-trillion-dollar airline market is what is really likely to drive the upside,” said the report. The stock is still way down from its IPO price of $10.14, and the Morgan Stanley analyst who wrote it admitted that the stock is a biotech-type risk.

  • When Should You Buy Cloudera, Inc. (NYSE:CLDR)?
    Business
    Simply Wall St.

    When Should You Buy Cloudera, Inc. (NYSE:CLDR)?

    Cloudera, Inc. (NYSE:CLDR), which is in the software business, and is based in United States, received a lot of attention from a substantial price increase on the NYSE over the last few months. Today I will analyse the most recent data on Cloudera's outlook and valuation to see if the opportunity still exists. Cloudera is still a bargain right now.

  • The Co-Founder of Evolent Health, Inc. (NYSE:EVH), Frank Williams, Just Bought 5.8% More Shares
    Business
    Simply Wall St.

    The Co-Founder of Evolent Health, Inc. (NYSE:EVH), Frank Williams, Just Bought 5.8% More Shares

    Potential Evolent Health, Inc. (NYSE:EVH) shareholders may wish to note that the Co-Founder, Frank Williams, recently bought US$228k worth of stock, paying US$6.51 for each share. In fact, the recent purchase by Frank Williams was the biggest purchase of Evolent Health shares made by an insider individual in the last twelve months, according to our records. The good news for Evolent Health share holders is that insiders were buying at near the current price.

  • Revenue tops estimates for Stitch Fix in first quarter
    Business
    Yahoo Finance Video

    Revenue tops estimates for Stitch Fix in first quarter

    After hour shares for Stich Fix are up after the company beat expectations for it first quarter earnings. Yahoo Finance's Seana Smith reports on "The Final Round."

  • Should You Buy Pluralsight, Inc. (PS)?
    Business
    Insider Monkey

    Should You Buy Pluralsight, Inc. (PS)?

    That's why we believe it isn't a waste of time to check out hedge fund sentiment before you invest in a stock like Pluralsight, Inc. NASDAQ:PS). Hedge fund interest in Pluralsight, Inc.

  • How Many Amyris, Inc. (NASDAQ:AMRS) Shares Did Insiders Buy, In The Last Year?
    Business
    Simply Wall St.

    How Many Amyris, Inc. (NASDAQ:AMRS) Shares Did Insiders Buy, In The Last Year?

    We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. We don't think shareholders should simply follow insider transactions. For example, a Columbia University study found that 'insiders are more likely to engage in open market purchases of their own company's stock when the firm is about to reveal new agreements with customers and suppliers'.

  • 2 Days Left Until The Walt Disney Company (NYSE:DIS) Trades Ex-Dividend
    Business
    Simply Wall St.

    2 Days Left Until The Walt Disney Company (NYSE:DIS) Trades Ex-Dividend

    Walt Disney's next dividend payment will be US$0.88 per share, on the back of last year when the company paid a total of US$1.76 to shareholders. Based on the last year's worth of payments, Walt Disney stock has a trailing yield of around 1.2% on the current share price of $146.21. Dividends are a major contributor to investment returns for long term holders, but only if the dividend continues to be paid.

  • Why Donald Trump Could Still Resign
    Politics
    Time

    Why Donald Trump Could Still Resign

    Resignation has always been a small-odds proposition for this egocentric President, but today the stars are more aligned for that result than ever before. Like in the Nixon case, the primer to the resignation bullet is in the hands of the Supreme Court. In Nixon, the President's lawyers defended against a subpoena for Oval Office tapes on the grounds of executive privilege.

  • Here's What Genesco Inc.'s (NYSE:GCO) P/E Ratio Is Telling Us
    Business
    Simply Wall St.

    Here's What Genesco Inc.'s (NYSE:GCO) P/E Ratio Is Telling Us

    The formula for P/E is: Price to Earnings Ratio = Share Price ÷ Earnings per Share (EPS) Or for Genesco: P/E of 15.59 = $48.82 ÷ $3.13 (Based on the year to August 2019. Is A High P/E Ratio Good? A higher P/E ratio means that buyers have to pay a higher price for each $1 the company has earned over the last year.

  • Is Ambev SA  (ABEV) A Good Stock To Buy?
    Business
    Insider Monkey

    Is Ambev SA (ABEV) A Good Stock To Buy?

    Hedge funds' top 3 stock picks returned 41.7% this year and beat the S&P 500 ETFs by 14 percentage points. Is Ambev SA (NYSE:ABEV) a healthy stock for your portfolio? ABEV was in 18 hedge funds' portfolios at the end of the third quarter of 2019.

  • Is Vodafone Group Plc  (VOD) A Good Stock To Buy?
    Business
    Insider Monkey

    Is Vodafone Group Plc (VOD) A Good Stock To Buy?

    Vodafone Group Plc (NASDAQ:VOD) has seen an increase in activity from the world's largest hedge funds recently. VOD was in 19 hedge funds' portfolios at the end of September. There were 11 hedge funds in our database with VOD positions at the end of the previous quarter.

  • Is New Residential Investment Corp (NRZ) A Good Stock To Buy ?
    Business
    Insider Monkey

    Is New Residential Investment Corp (NRZ) A Good Stock To Buy ?

    Brookfield was right about politics as stocks experienced their second worst May since the 1960s due to escalation of trade disputes. Insider Monkey's flagship short hedge fund strategy outstripped the S&P 500 short ETFs by around 20 percentage points per year since its inception in May 2014.

  • Hedge Funds Are Crazy About Yamana Gold Inc. (AUY)
    Business
    Insider Monkey

    Hedge Funds Are Crazy About Yamana Gold Inc. (AUY)

    Is Yamana Gold Inc. NYSE:AUY) a healthy stock for your portfolio? Money managers are becoming more confident.

  • Business
    Thomson Reuters StreetEvents

    Edited Transcript of ASNA earnings conference call or presentation 9-Dec-19 9:30pm GMT

    Starting with product, we are making progress and leveraging customer insights gained from our advanced data analytics to deliver the right product at the right time as we address their lifestyle needs and continually provide a compelling assortment. Across our brands, we have tightened our test-and-react approach to more quickly respond to our preferences and shopping behaviors. We saw the biggest benefits of these insights in the performance of our Plus business this quarter.

  • Flexion Therapeutics (NASDAQ:FLXN) Shareholders Have Enjoyed A 40% Share Price Gain
    Business
    Simply Wall St.

    Flexion Therapeutics (NASDAQ:FLXN) Shareholders Have Enjoyed A 40% Share Price Gain

    To wit, the Flexion Therapeutics, Inc. (NASDAQ:FLXN) share price is 40% higher than it was a year ago, much better than the market return of around 18% (not including dividends) in the same period. As you can imagine, fast revenue growth, when maintained, often leads to fast profit growth. The solid 40% share price gain goes down pretty well, but it's not necessarily as good as you might expect given the top notch revenue growth.